Irina Kufareva
Citeras av
Citeras av
Sirtuin 2 inhibitors rescue α-synuclein-mediated toxicity in models of Parkinson's disease
TF Outeiro, E Kontopoulos, SM Altmann, I Kufareva, KE Strathearn, ...
science 317 (5837), 516-519, 2007
Structure of the CCR5 chemokine receptor–HIV entry inhibitor maraviroc complex
Q Tan, Y Zhu, J Li, Z Chen, GW Han, I Kufareva, T Li, L Ma, G Fenalti, J Li, ...
Science 341 (6152), 1387-1390, 2013
The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer
M O'hayre, J Vázquez-Prado, I Kufareva, EW Stawiski, TM Handel, ...
Nature Reviews Cancer 13 (6), 412-424, 2013
Crystal structure of the human cannabinoid receptor CB1
T Hua, K Vemuri, M Pu, L Qu, GW Han, Y Wu, S Zhao, W Shui, S Li, ...
Cell 167 (3), 750-762. e14, 2016
Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine
L Qin, I Kufareva, LG Holden, C Wang, Y Zheng, C Zhao, G Fenalti, H Wu, ...
Science 347 (6226), 1117-1122, 2015
Status of GPCR modeling and docking as reflected by community-wide GPCR Dock 2010 assessment
I Kufareva, M Rueda, V Katritch, G Dock, RC Stevens, R Abagyan
Structure 19 (8), 1108-1126, 2011
Methods of protein structure comparison
I Kufareva, R Abagyan
Homology Modeling, 231-257, 2011
Structure-Based Discovery of Novel Chemotypes for Adenosine A2A Receptor Antagonists
V Katritch, VP Jaakola, JR Lane, J Lin, AP IJzerman, M Yeager, I Kufareva, ...
Journal of medicinal chemistry 53 (4), 1799-1809, 2010
Structure of CC chemokine receptor 2 with orthosteric and allosteric antagonists
Y Zheng, L Qin, NVO Zacarías, H de Vries, GW Han, M Gustavsson, ...
Nature 540 (7633), 458-461, 2016
Four-dimensional docking: a fast and accurate account of discrete receptor flexibility in ligand docking
G Bottegoni, I Kufareva, M Totrov, R Abagyan
Journal of medicinal chemistry 52 (2), 397-406, 2009
Chemokine and chemokine receptor structure and interactions: implications for therapeutic strategies
I Kufareva, CL Salanga, TM Handel
Immunology and cell biology 93 (4), 372-383, 2015
Type-II kinase inhibitor docking, screening, and profiling using modified structures of active kinase states
I Kufareva, R Abagyan
Journal of medicinal chemistry 51 (24), 7921-7932, 2008
3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis
T Hayashi, JH Mo, X Gong, C Rossetto, A Jang, L Beck, GI Elliott, ...
Proceedings of the National Academy of Sciences 104 (47), 18619-18624, 2007
Advances in GPCR modeling evaluated by the GPCR Dock 2013 assessment: meeting new challenges
I Kufareva, V Katritch, RC Stevens, R Abagyan
Structure 22 (8), 1120-1139, 2014
Pocketome: an encyclopedia of small-molecule binding sites in 4D
I Kufareva, AV Ilatovskiy, R Abagyan
Nucleic acids research 40 (D1), D535-D540, 2012
PIER: protein interface recognition for structural proteomics
I Kufareva, L Budagyan, E Raush, M Totrov, R Abagyan
Proteins: Structure, Function, and Bioinformatics 67 (2), 400-417, 2007
Structure of CC chemokine receptor 5 with a potent chemokine antagonist reveals mechanisms of chemokine recognition and molecular mimicry by HIV
Y Zheng, GW Han, R Abagyan, B Wu, RC Stevens, V Cherezov, ...
Immunity 46 (6), 1005-1017. e5, 2017
Viral infection controlled by a calcium-dependent lipid-binding module in ALIX
C Bissig, M Lenoir, MC Velluz, I Kufareva, R Abagyan, M Overduin, ...
Developmental cell 25 (4), 364-373, 2013
A new method for ligand docking to flexible receptors by dual alanine scanning and refinement (SCARE)
G Bottegoni, I Kufareva, M Totrov, R Abagyan
Journal of Computer-Aided Molecular Design 22 (5), 311-325, 2008
Structure based prediction of subtype-selectivity for adenosine receptor antagonists
V Katritch, I Kufareva, R Abagyan
Neuropharmacology 60 (1), 108-115, 2011
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20